[68Ga]Ga-DOTA-DP-UBI 29-41: A Novel 68Ga-Labeled Ubiquicidin 29-41 Derivative Containing d -Proline for Bacterial Infection PET Imaging
Molecular Pharmaceutics · 03.08.2026 · 23 (8) · 4263-4272
DOI: 10.1021/acs.molpharmaceut.6c00462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 02.07.2026. Verfasst von Yuhao Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (Nationa…. Hauptthemen laut MEDLINE: Proline, Positron-Emission Tomography, Gallium Radioisotopes, Radiopharmaceuticals. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Bacterial infection poses a persistent and severe threat to human health. Accurate differentiation between bacterial infection and sterile inflammation is critical for timely clinical treatment. In this study, a novel 68Ga-labeled radiotracer ([68Ga]Ga-DOTA-DP-UBI 29-41) was radiosynthesized by labeling the UBI 29-41 derivative (DOTA-DP-UBI 29-41) with 68Ga. This radiotracer was designed by introducing d-proline (DP) as a linker between the ubiquicidin 29-41 (UBI 29-41) targeting segment and the 1,4,7,10-tetraazacyclododecane-N,N′,N,N′-tetraacetic acid (DOTA) chelating group. The radiotracer exhibited high radiochemical purity (RCP > 98%) and favorable in vitro stability in normal saline at room temperature and mouse serum at 37 °C, with hydrophilic properties (LogD = −3.58 ± 0.04). In vitro bacterial experiments confirmed the specific and rapid binding of this radiotracer to Staphylococcus aureus, with binding reaching equilibrium within 30 min of incubation and exhibiting concentration-dependent competitive inhibition with UBI 29-41. Biodistribution studies in mouse models revealed effective accumulation of the tracer at bacterial infection sites (1.98 ± 0.66% ID/g at 30 min p.i.), significantly lower renal uptake (stabilized at ∼25% ID/g) than previous 68Ga-labeled UBI 29-41 derivatives, and a distinct difference in uptake between bacterium-infected and sterile inflamed muscles (an infection-to-inflammation ratio of 2.11 at 120 min p.i.). PET/CT imaging further confirmed that the tracer could clearly visualize bacterial infection foci and distinguish infection from sterile inflammation in dual-pathology mice, with rapid blood clearance kinetics, renal metabolism, and excretion. Collectively, these results indicate that [68Ga]Ga-DOTA-DP-UBI 29-41 will be a promising PET tracer for the specific diagnosis of bacterial infection and differentiation from sterile inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Product Administration), Beijing Key Laboratory of Innovativ…
- Key Laboratory of Beam Technology of the Ministry of Education, School of Physics and Astronomy, Beijing Normal University, Beijing100875, China.
ORCID-Profile: Yuhao Jiang, Peiwen Han, Ziqing Zhao, Junbo Zhang
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Jiang, Y., Han, P., Qian, Y., Zhang, L., Sun, Y., Yin, G., Ding, D., Diao, L., Zhao, Z., Jiang, J., & Zhang, J. (2026). [68Ga]Ga-DOTA-DP-UBI 29-41: A Novel 68Ga-Labeled Ubiquicidin 29-41 Derivative Containing d -Proline for Bacterial Infection PET Imaging. Molecular Pharmaceutics, 23(8), 4263-4272. https://doi.org/10.1021/acs.molpharmaceut.6c00462
Vancouver
Jiang Y, Han P, Qian Y, Zhang L, Sun Y, Yin G, et al. [68Ga]Ga-DOTA-DP-UBI 29-41: A Novel 68Ga-Labeled Ubiquicidin 29-41 Derivative Containing d -Proline for Bacterial Infection PET Imaging. Molecular Pharmaceutics. 2026;23(8):4263-4272. doi:10.1021/acs.molpharmaceut.6c00462
BibTeX
@article{Jiang2026,
author = {Jiang, Yuhao and Han, Peiwen and Qian, Yu and Zhang, Liyin and Sun, Yifu and Yin, Guangxing and Ding, Dajie and Diao, Lina and Zhao, Ziqing and Jiang, Jianyong and Zhang, Junbo},
title = {[68Ga]Ga-DOTA-DP-UBI 29-41: A Novel 68Ga-Labeled Ubiquicidin 29-41 Derivative Containing d -Proline for Bacterial Infection PET Imaging},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {8},
pages = {4263--4272},
doi = {10.1021/acs.molpharmaceut.6c00462}
}
EUVIMED